The Highly Effective Monoclonal Antibody Treatment Against COVID-19 That Dr Fauci Won’t Tell You About

There’s a free, highly effective treatment called the Monoclonal Antibody Treatment for those who contract COVID-19 and its variants that could immediately relieve hospitals and slow the pandemic, but Dr Fauci has been tight-lipped about the lifesaving care.

Monoclonal Antibody Treatment COVID-19

Monoclonal antibody treatment has been found to reduce hospitalization and death from COVID by a stunning 70%, with almost no side effects, based on preliminary findings in recent studies. It’s also been shown to shorten the duration of symptoms by four days.

Yet, awareness of the treatment is abysmal — and that’s in large part due to the efforts — or lack of effort — from Dr. Fauci himself.

You likely first heard of such treatment from former President Donald Trump, who famously had the antibody infusion when he was infected with COVID and made a quick turnaround.

At the time, the treatment was not yet available to the public, and the media bashed Trump for calling the treatment a “cure”, reported Amanda Prestigiacomo for the Daily Wire.

Since then, the treatment has been authorized for public use and has been widely praised by many doctors, patients, and public health officials — including some from the US government.

But word of the treatment and its availability is just not getting out fast enough.

What is Monoclonal Antibody Treatment

The antibody treatment is essentially an infusion of supplemental antibodies that help your body fight off COVID — and fast, according to medical experts.

University of Alabama at Birmingham Professor Turner Overton explained it this way:

Your “immune system takes two to three weeks to make good antibodies,” but “monoclonal antibodies are supplemental antibodies that can be administered early in the course of infection — the first 10 days after symptoms commence — to rapidly bind and kill the COVID virus.”

Medical experts suggest that the treatment should be given to COVID-positive patients during the first ten days of symptoms.

“This is the golden goose, okay, this is what we need, and we’ve got a short window to get these people treated,” said Dr. David Thrasher, a pulmonologist from Alabama. “This is the only thing in COVID that I’ve seen that is not controversial.”

“It is incredibly effective if given early enough,” Dr. Overton said of the antibody treatment, adding that the care is “lifesaving.”

Dr. Sujesh Pillai, Chief of Staff for Huntsville Memorial, said the hospital administered more than 50 infusions in a matter of two weeks, and only one person had to be admitted to the hospital.

“When you get the infusion treatment, it’s a one-hour IV infusion that we do in the hospital. You’re not admitted. You go home right after it’s done,” Pillai said.

“It’s very well tolerated. It has been shown to have about 70 to 80% chance of preventing you from developing severe COVID or ending up coming to the hospital at all and helping you get a full recovery.”

Erin McCreary, director of stewardship innovation at the University of Pittsburgh Medical Center, called the treatment “absolutely the standard of care for COVID-19. It is my hope that clinics know that.”

Dr. Samuel L. Jacobs, a physician at the Florida Department of Health in Broward County, noted, “I had received my first dose of the vaccine prior to contracting COVID and I think the monoclonal antibody treatment saved my life and I’m very grateful.

If someone tests positive for COVID and especially if they’re having symptoms, I strongly stress the importance of getting monoclonal antibodies basically as a life-saving measure.” 

“The monoclonal antibodies work,” said Marcella Nunez-Smith, chair of the government’s COVID-19 Health Equity Task Force. “They are safe, they’re free, they keep people out of the hospital, and help keep them alive.”

“The Maryland Department of Health (MDH) is actively encouraging physicians and patients to consider monoclonal antibody treatment, which has been shown to reduce the severity of symptoms and prevent hospitalization in people with mild or moderate symptoms of COVID-19,” reads a press release from MDH.

Why isn’t the treatment being promoted properly? 

Why isn’t Monoclonal Antibody Treatment being promoted properly? 

Last week, Florida Gov. Ron DeSantis (R), who is without question leading the way to promote early care like antibody treatment, suggested some public health officials bypassed promotion of the treatment in an effort to drive behavior.

Basically, officials were scared if Americans knew about the highly effective treatment, they might forgo a vaccine. DeSantis emphasized the importance of vaccination but criticized those, in his opinion, neglecting to inform the public about all their options and care.

GreatGameIndia is being actively targeted by powerful forces who do not wish us to survive. Your contribution, however small help us keep afloat. We accept voluntary payment for the content available for free on this website via UPI, PayPal and Bitcoin.

Support GreatGameIndia


  1. Ivermectin works even better, but the problem here is that it costs pennies and ruins for some interested parties the prospect of making a lot of money if people get healed at no cost

  2. If they publish that monoclonal antibodies is a good treatment against Covid-19, then the mRNA vaccines will not get approval. But then Pfizer & Co will claim that their mRNA vaccines are not vaccines after all, contrary to what they have been claiming from the beginning until now.

Leave a Reply